MINK1 and primary biliary cholangitis: MINK1 mitigates autoimmune damage by inhibiting Th17 cell differentiation, and since PBC involves Th17-mediated injury (Fu et al., 2017), it may reduce biliary autoimmune attacks via suppressing Th17 activity.